FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:480-482 February 11, 1999 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Abenhaim, L. PubMed Citation

To the Editor: The article by Abenhaim et al.¹ on the association of anorectic drugs and primary pulmonary hypertension contributed to public concern about the use of these drugs and the subsequent withdrawal of dexfenfluramine from the market. The association between anorectic drugs and primary pulmonary hypertension rested largely on the high odds ratio for the development of pulmonary hypertension with the use of anorectic drugs, the demonstration that the incidence of primary pulmonary hypertension increased with the duration of exposure, and the suggestion that obvious confounding factors were considered.

I am writing to report discrepancies between the article and . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Shah, S. J., Gomberg-Maitland, M., Thenappan, T., Rich, S. (2009). Selective Serotonin Reuptake Inhibitors and the Incidence and Outcome of Pulmonary Hypertension. Chest 136: 694-700 [Abstract] [Full Text]